John L. Marshall, MD, on Accessibility of Precision Medicine
The expert from the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers discussed precision medicine with regard to cancer care, as well as the need to make such care more accessible for the global community.
In an article published in the journal Oncology®, John L. Marshall, MD, of the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers, discussed precision medicine with regard to cancer care, as well as the need to make such care more accessible for the global community.
“Cancer care can no longer be a luxury item, only for the rich. We must work toward wide access,” Marshall wrote. “Opening markets through collaborative science will secure the return on investment for our business partners, and secure our progress toward finding the cures for cancer.”
In an interview with CancerNetwork®, Marshall spoke about his paper further and why precision medicine will change global cancer care for decades to come.
This segment comes from the CancerNetwork® portion of the MJH Life Sciences Medical World News, airing daily on all MJH Life Sciences channels.
Reference:
Marshall JL. The Prospective Incorporation of Molecular Profiling Will Transform Global Cancer Care. Oncology. https://www.cancernetwork.com/view/the-prospective-incorporation-of-molecular-profiling-will-transform-global-cancer-care
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F9b290688648a249e516474c175a3c06309426d15-2950x1568.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.")
